Skip to content
★ Sign in to follow
Total declarations
25
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (11 ops.)
€1.8M

Latest filing published 23 Feb 2021 for OMEROS CORP, €85k.

Filing timeline

BuySale
Michael A. Jacobsen

Insider track record

Disclosed buys
0
Disclosed sells
11
Signal history

Michael A. Jacobsen: trading record in brief

This profile gathers the share dealings of Michael A. Jacobsen across 2 companies, led by Omeros Corp and Sarepta Therapeutics, Inc. Between 23 August 2012 and 22 February 2021, the trades on record add up to 25 filings.

No open-market purchase appears, only 11 sales worth €1.8M. Besides market trades, the filings include 1 share grant and 13 option exercises. 2021 to date brings no purchases and 4 sales.

Most recently, on 23 February 2021, the filings show an open-market sale worth €156k in Omeros Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Michael A. Jacobsen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations25 total
  • ◇
    VP FINANCE AND CAOExecutivesOmeros Corp
    102,700 USD11SEC
    10,000 shares@ US$10.273.3% of flowCommon StockSEC:0001415889-21-000881:0
  • ▼
    VP FINANCE AND CAOExecutivesOmeros Corp
    226,400 USD12SEC
    10,000 shares@ US$22.647.2% of flowCommon StockSEC:0001415889-21-000881:1
  • ◇
    VP FINANCE AND CAOExecutivesOmeros Corp
    83,187 USD11SEC
    8,100 shares@ US$10.272.6% of flowCommon StockSEC:0001415889-21-000881:2
  • ▼
    VP FINANCE AND CAOExecutivesOmeros Corp
    188,568 USD12SEC
    8,100 shares@ US$23.286.0% of flowCommon StockSEC:0001415889-21-000881:3
  • ◇
    VP FINANCE AND CAOExecutivesOmeros Corp
    19,513 USD11SEC
    1,900 shares@ US$10.270.6% of flowCommon StockSEC:0001415889-21-000668:0
  • ▼
    VP FINANCE AND CAOExecutivesOmeros Corp
    42,731 USD23SEC
    1,900 shares@ US$22.491.4% of flowCommon StockSEC:0001415889-21-000668:1
  • ▼
    VP FINANCE AND CAOExecutivesOmeros Corp
    189,525 USD24SEC
    9,500 shares@ US$19.956.0% of flowCommon StockSEC:0001415889-21-000362:0
  • ◇
    VP FINANCE AND CAOExecutivesOmeros Corp
    93,700 USD11SEC
    10,000 shares@ US$9.373.0% of flowCommon StockSEC:0001415889-21-000362:1
  • ◇
    VP Finance and CAOExecutivesOmeros Corp
    102,883 USD11SEC
    10,980 shares@ US$9.374.7% of flowCommon StockSEC:0000899243-18-013086:0
  • ▼
    VP Finance and CAOExecutivesOmeros Corp
    246,501 USD12SEC
    10,980 shares@ US$22.4511.3% of flowCommon StockSEC:0000899243-18-013086:1
  • ◇
    VP Finance and CAOExecutivesOmeros Corp
    120,048 USD12SEC
    12,812 shares@ US$9.375.6% of flowCommon StockSEC:0000899243-18-013086:2
  • ▼
    VP Finance and CAOExecutivesOmeros Corp
    319,659 USD12SEC
    12,812 shares@ US$24.9514.8% of flowCommon StockSEC:0000899243-18-013086:3
  • ◇
    VP Finance and CAOExecutivesOmeros Corp
    46,850 USD11SEC
    5,000 shares@ US$9.372.2% of flowCommon StockSEC:0000899243-18-013086:4
  • ◇
    VP Finance and CAOExecutivesOmeros Corp
    9,557 USD11SEC
    1,020 shares@ US$9.370.4% of flowCommon StockSEC:0000899243-18-000628:0
  • ▼
    VP Finance and CAOExecutivesOmeros Corp
    22,899 USD23SEC
    1,020 shares@ US$22.451.0% of flowCommon StockSEC:0000899243-18-000628:1
  • ◇
    VP Finance and CAOExecutivesOmeros Corp
    9,370 USD11SEC
    1,000 shares@ US$9.370.4% of flowCommon StockSEC:0000899243-18-000628:2
  • ◇
    VP Finance and CAOExecutivesOmeros Corp
    131,180 USD12SEC
    14,000 shares@ US$9.376.4% of flowCommon StockSEC:0000899243-17-016625:0
  • ▼
    VP Finance and CAOExecutivesOmeros Corp
    299,400 USD12SEC
    12,000 shares@ US$24.9514.7% of flowCommon StockSEC:0000899243-17-016625:1
  • ◇
    VP Finance and CAOExecutivesOmeros Corp
    24,831 USD11SEC
    2,650 shares@ US$9.371.2% of flowCommon StockSEC:0000899243-17-016504:0
  • ▼
    VP Finance and CAOExecutivesOmeros Corp
    52,868 USD11SEC
    2,650 shares@ US$19.952.6% of flowCommon StockSEC:0000899243-17-016504:1
  • ◇
    VP Finance and CAOExecutivesOmeros Corp
    120,405 USD12SEC
    12,850 shares@ US$9.375.9% of flowCommon StockSEC:0000899243-17-016504:2
  • ▼
    VP Finance and CAOExecutivesOmeros Corp
    186,533 USD12SEC
    9,350 shares@ US$19.959.1% of flowCommon StockSEC:0000899243-17-016504:3
  • ◇
    VP Finance and CAOExecutivesOmeros Corp
    131,180 USD12SEC
    14,000 shares@ US$9.376.4% of flowCommon StockSEC:0000899243-17-016504:4
  • ▼
    VP Finance and CAOExecutivesOmeros Corp
    269,400 USD12SEC
    12,000 shares@ US$22.4513.2% of flowCommon StockSEC:0000899243-17-016504:5
  • ◆
    VP of Finance and PAOExecutivesSarepta Therapeutics, Inc.
    0SEC
    7,500 shares0Common StockSEC:0001181431-12-047606:0

25 of 25 declarations